Healthcare -
Biotechnology - NASDAQ - US
$ 8.92
12 %
$ 482 M
Market Cap
-5.22
P/E
STOK - REVENUE
Revenue STOK - Stoke Therapeutics, Inc.
36.6 M
LAST VALUE
71.66%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR